Skip to content

Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection

Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00670020
Enrollment
143
Registered
2008-05-01
Start date
2001-01-31
Completion date
2006-12-31
Last updated
2008-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Infection or Endometritis Post Cesarean Section

Keywords

Women undergoing Cesarean section after the onset of labor

Brief summary

The purpose of this study is to determine whether supplemental perioperative oxygen significantly decreases the incidence of post-Cesarean endometritis and wound infection among women who undergo Cesarean section after the onset of labor.

Detailed description

Women undergoing cesarean section after rupture of membranes or onset of labor are randomized in a one to one ratio to either normal or supplemental perioperative oxygen during cesarean section and for two hours afterwards.

Interventions

increased perioperative oxygen verses non-interventional oxygen

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women who underwent a clinically indicated cesarean delivery after the onset of labor or rupture of membranes

Exclusion criteria

* Cesarean delivery prior to the onset of labor or rupture of membranes * emergent cesarean delivery * general endotracheal anesthesia * clinical chorioamnionitis * HIV infection * less than 16 years of age

Design outcomes

Primary

MeasureTime frame
surgical site infectionwithin two weeks of cesarean section

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026